TNFalpha suppresses link protein and type II collagen expression in chondrocytes: Role of MEK1/2 and NF-kappaB signaling pathways
- PMID: 14566965
- DOI: 10.1002/jcp.10371
TNFalpha suppresses link protein and type II collagen expression in chondrocytes: Role of MEK1/2 and NF-kappaB signaling pathways
Abstract
Tumor necrosis factor alpha (TNFalpha) inhibits matrix synthesis by chondrocytes in rheumatoid arthritis and osteoarthritis; however, the underlying signaling pathways are poorly characterized. This study investigated the TNFalpha-activated pathways regulating expression of two key components of the cartilage matrix-link protein and type II collagen. In rat articular chondrocytes, TNFalpha decreased link protein and type II collagen mRNA to undetectable levels within 48 h. Levels of link protein mRNA recovered more readily than type II collagen mRNA following removal of the cytokine. TNFalpha-mediated reduction in mRNA of both matrix molecules occurred at the level of transcription and, for link protein, mRNA stability. Turnover of type II collagen and link protein mRNA was dependent on new protein synthesis. In both prechondrocytes and articular chondrocytes, TNFalpha induced concentration-dependent activation of MEK1/2 and NF-kappaB, but not p38 or JNK. Sustained activation of NF-kappaB was observed for up to 72 h following continuous or transient exposure to TNFalpha. Using pharmacological and molecular approaches, the MEK1/2 and NF-kappaB pathways were found to mediate inhibition of type II collagen and link protein gene expression by TNFalpha. Both prechondrocytes and articular chondrocytes are targets of TNFalpha. This study identifies pathways through which TNFalpha perturbs the synthesis and organization of articular cartilage matrix during inflammation.
Similar articles
-
The catabolic pathway mediated by Toll-like receptors in human osteoarthritic chondrocytes.Arthritis Rheum. 2006 Jul;54(7):2152-63. doi: 10.1002/art.21951. Arthritis Rheum. 2006. PMID: 16802353
-
Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes.Arthritis Res Ther. 2007;9(2):R31. doi: 10.1186/ar2151. Arthritis Res Ther. 2007. PMID: 17386086 Free PMC article.
-
N-butyryl glucosamine increases matrix gene expression by chondrocytes.J Pharmacol Exp Ther. 2004 Nov;311(2):610-6. doi: 10.1124/jpet.104.067769. Epub 2004 Jul 7. J Pharmacol Exp Ther. 2004. PMID: 15240824
-
Effects of interferon-gamma and tumor necrosis factor alpha on the expression of the genes encoding aggrecan, biglycan, and decorin core proteins in cultured human chondrocytes.Arthritis Rheum. 1998 Feb;41(2):274-83. doi: 10.1002/1529-0131(199802)41:2<274::AID-ART11>3.0.CO;2-Z. Arthritis Rheum. 1998. PMID: 9485085 Review.
-
Integrins and cell signaling in chondrocytes.Biorheology. 2002;39(1-2):119-24. Biorheology. 2002. PMID: 12082274 Review.
Cited by
-
Lentivirus-induced knockdown of LRP1 induces osteoarthritic-like effects and increases susceptibility to apoptosis in chondrocytes via the nuclear factor-κB pathway.Exp Ther Med. 2015 Jul;10(1):97-105. doi: 10.3892/etm.2015.2471. Epub 2015 May 5. Exp Ther Med. 2015. PMID: 26170918 Free PMC article.
-
The potential roles of JAK/STAT signaling in the progression of osteoarthritis.Front Endocrinol (Lausanne). 2022 Nov 24;13:1069057. doi: 10.3389/fendo.2022.1069057. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36506076 Free PMC article. Review.
-
Mechanism of Wenshen Xuanbi Decoction in the treatment of osteoarthritis based on network pharmacology and experimental verification.Korean J Physiol Pharmacol. 2024 Jan 1;28(1):59-72. doi: 10.4196/kjpp.2024.28.1.59. Korean J Physiol Pharmacol. 2024. PMID: 38154965 Free PMC article.
-
Recently highlighted nutraceuticals for preventive management of osteoarthritis.World J Orthop. 2018 Nov 18;9(11):255-261. doi: 10.5312/wjo.v9.i11.255. eCollection 2018 Nov 18. World J Orthop. 2018. PMID: 30479972 Free PMC article. Review.
-
Induction of an osteoarthritis-like phenotype and degradation of phosphorylated Smad3 by Smurf2 in transgenic mice.Arthritis Rheum. 2008 Oct;58(10):3132-44. doi: 10.1002/art.23946. Arthritis Rheum. 2008. PMID: 18821706 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous